We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-28.95%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$79.3M
AUM Growth
-$67.7M
Cap. Flow
-$24.1M
Cap. Flow %
-30.41%
Top 10 Hldgs %
54.45%
Holding
159
New
32
Increased
24
Reduced
41
Closed
43

Sector Composition

Rank Sector Weight
1 Healthcare 36.68%
2 Technology 5.89%
3 Consumer Discretionary 4.32%
4 Industrials 3.44%
5 Energy 1.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BJDX icon
101
Bluejay Diagnostics
BJDX
$1.03M
$20K 0.03%
1
AGRX
102
DELISTED
Agile Therapeutics
AGRX
$15K 0.02%
+1,000
New +$24.6K
NCTY
103
The9 Ltd
NCTY
$70.6M
$14K 0.02%
1,445
NEXRW
104
Nexera Technologies Ltd Warrant
NEXRW
$13K 0.02%
+77,282
New +$21.3K
NBEV
105
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$13K 0.02%
1,266,800
-2,781,411
-69% -$713K
SPI
106
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$13K 0.02%
10,226
-7,169
-41% -$12.9K
SPI
107
PUT
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$13K 0.02%
100
-74
-43% -$133
NMTR
108
CALL
DELISTED
9 Meters Biopharma
NMTR
$12K 0.02%
27
-124
-82% -$615
BRSH
109
DELISTED
Bruush Oral Care Inc. Common Stock
BRSH
$10K 0.01%
+409
New +$17.3K
EQOS
110
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$10K 0.01%
23,854
-12,500
-34% -$8.21K
BBLGW
111
Bone Biologics Corp Warrants
BBLGW
$32.7M
$9K 0.01%
3,616
FEED
112
ENvue Medical Inc
FEED
$2.09M
$5K 0.01%
5
CRXT
113
DELISTED
Clarus Therapeutics Holdings, Inc. Common Stock
CRXT
$5K 0.01%
146,900
-53,100
-27% -$16.3K
GMBLW
114
PUT
DELISTED
Esports Entertainment Group Inc. Warrant
GMBLW
$2K ﹤0.01%
200
MKD
115
DELISTED
Molecular Data Inc. American Depositary Shares
MKD
$2K ﹤0.01%
+178,972
New +$94.5K
GROMW
116
DELISTED
Grom Social Enterprises Inc. Warrants
GROMW
$1K ﹤0.01%
425
ANY icon
117
Sphere 3D
ANY
$16.8M
-3,046
Closed -$138K
ANY icon
118
PUT
Sphere 3D
ANY
$16.8M
-33
Closed -$123K
ATNM icon
119
CALL
Actinium Pharmaceuticals
ATNM
$27.2M
-2,049
Closed -$986K
BEAT icon
120
Heartbeam
BEAT
$29.3M
-195,000
Closed -$252K
SLAI
121
DELISTED
SOLAI Ltd ADS
SLAI
-1,332
Closed -$58K
SLAI
122
PUT
DELISTED
SOLAI Ltd ADS
SLAI
-5
Closed -$21K
CBAT icon
123
CBAK Energy Technology Ltd
CBAT
$43.6M
-20,298
Closed -$26K
MBAI
124
Check-Cap
MBAI
$8.12M
-15,013
Closed -$93K
GEVO icon
125
CALL
Gevo
GEVO
$363M
-3,226
Closed -$758K

Similar funds

Sabby Management's Q3 2022 Portfolio in Review

As of Q3 2022, Sabby Management held 159 positions worth $79.3M, down 46% from $147M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Sabby Management withdrew a net $24.1M in Q3 2022, closing 43 positions and reducing 41 holdings. Its most notable exit was Gevo, an estimated $15.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Sabby Management opened a new position in Bright Green Corporation Common Stock worth $5.14M.

  • Sabby Management's largest Q3 2022 buy was Bright Green Corporation Common Stock: 4,761,905 shares worth $5.14M.
  • Sabby Management added most to Dogness International Corp in Q3 2022, an estimated $513K increase.
  • Sabby Management's biggest Q3 2022 reduction was BioVie, cutting an estimated $1.26M.
  • Sabby Management fully exited Gevo in Q3 2022, selling an estimated $15.3M.
  • Sabby Management's ten largest holdings make up 54% of its $79.3M portfolio in Q3 2022.
  • Sabby Management opened 32 new positions and closed 43 in Q3 2022.
  • Sabby Management's portfolio value fell 46% quarter-over-quarter to $79.3M.

Based on Sabby Management's 13F filing for Q3 2022, filed 14 Nov 2022.